| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:02 | Custom Health Holdings Inc.: Custom Health Highlights Early Results with BKC Pain Specialists, Supporting Expansion of Chronic Pain Program | 198 | Newsfile | Custom Health's existing commercial program with BKC Pain Specialists & Regenerative Medicine Clinic in Ohio is demonstrating early results through the integration of in-home medication technology,... ► Artikel lesen | |
| 08.09. | Stocks in Play: Custom Health Holdings Inc. | 1 | Baystreet.ca | ||
| 08.09. | Custom Health Holdings Inc: Custom Health completes acquisition of Spencer Health | 1 | Stockwatch | ||
| 08.09. | Custom Health schließt Übernahme von Spencer Health für 25 Mio. US-Dollar ab | 3 | Investing.com Deutsch | ||
| 08.09. | Custom Health completes Spencer Health acquisition for $25m | 4 | Investing.com | ||
| 08.09. | Custom Health Holdings Inc.: Custom Health Completes Acquisition of Spencer Health Solutions, Bringing In-Home Medication Dispensing Technology Fully In-House | 447 | Newsfile | Effective September 4, 2026, Custom Health has completed its previously announced acquisition of Spencer Health Solutions, developer of the spencer smart medication dispenser and in-home monitoring... ► Artikel lesen | |
| CUSTOM HEALTH Aktie jetzt für 0€ handeln | |||||
| 18.08. | Custom Health Holdings Inc. GAAP EPS of $1.29, revenue of $7.38M | 1 | Seeking Alpha | ||
| 18.08. | Custom Health Holdings Inc.: Custom Health Achieves 70% Increase in Quarterly Revenue in Q2-2026 and Advances Medication Management Platform with Evergreen Pharmacy and Spencer Health Solutions Acquisitions | 746 | Newsfile | For the three months ended June 30, 2026, Custom Health achieved quarterly revenue of US$7.4 million, an increase of 70% from Q2-2025. The results reflect the acquisition of InnovativeRx during... ► Artikel lesen | |
| 05.08. | Custom Health Holdings Inc: Custom Health enters deal to acquire Spencer Health | 1 | Stockwatch | ||
| 05.08. | Custom Health Holdings Inc.: Custom Health to Acquire Spencer Health Solutions, Strengthening Its Medication Management Infrastructure at Home | 739 | Newsfile | Custom Health has entered into a definitive agreement to acquire Spencer Health Solutions, which is expected to unite Custom Health's pharmacist-led medication management platform with the spencer... ► Artikel lesen | |
| 22.07. | Custom Health Holdings Inc: Custom Health agrees to buy Evergreen pharmacy | 1 | Stockwatch | ||
| 22.07. | Stocks in Play: Custom Health Holdings Inc | 1 | Baystreet.ca | ||
| 22.07. | Custom Health to acquire Evergreen Pharmacy for $3.5M | 3 | Seeking Alpha | ||
| 22.07. | Custom Health Holdings Inc.: Custom Health Announces Binding Letter of Intent to Acquire Evergreen Pharmacy; Expected to Add Over US$78 Million in Annual Revenue | 690 | Newsfile | Custom Health has entered into a binding letter of intent (the "LOI") to acquire Evergreen Pharmacy LLC ("Evergreen"), a Wisconsin-based specialty pharmacy specializing in the management of complex... ► Artikel lesen | |
| 08.07. | Custom Health: Delivering Healthcare Through AI-Enabled Technology | 1 | The Market Online Canada | ||
| 03.07. | Custom Health Holdings Inc: Custom Health loses $8.05-million (U.S.) in Q1 | 3 | Stockwatch | ||
| 03.07. | Stocks in Play: Custom Health Holdings Inc. | 1 | Baystreet.ca | ||
| 03.07. | Custom Health Holdings Inc.: Custom Health Delivers US$51.6 Million Proforma Annualized Revenue Run-Rate in Q1-2026 | 807 | Newsfile | For the three months ended March 31, 2026, Custom Health achieved quarterly revenue of US$4.3 million, while InnovativeRx (as defined below) achieved record quarterly revenue of US$8.6 million,... ► Artikel lesen | |
| 25.06. | Custom Health Holdings Inc: Custom Health appoints Guzman chief compliance officer | 1 | Stockwatch | ||
| 25.06. | Custom Health Holdings Inc.: Custom Health Announces Strategic Leadership Appointments to Support Continued Growth and Regulatory Excellence | 536 | Newsfile | Robert Guzman has been appointed Chief Compliance & Regulatory Officer, bringing extensive experience in regulatory oversight, compliance management, and quality assurance to strengthen Custom Health's... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 51,01 | -0,02 % | Heartflow, Inc.: Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026 | ||
| BILLIONTOONE | 101,03 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report Third Quarter 2026 Financial Results on November 4, 2026 | ||
| BRIGHTSPRING HEALTH SERVICES | 61,25 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 45,090 | +0,41 % | EQS-News: Fresenius SE & Co. KGaA: Aufsichtsrat beruft Dr. Marc-Alexander Mahl in den Vorstand und verlängert Vertrag von Sara Hennicken | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Personalie
Aufsichtsrat beruft Dr. Marc-Alexander Mahl in den Vorstand und verlängert Vertrag von Sara Hennicken (News mit Zusatzmaterial)
15.10.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,270 | +0,58 % | Siemens Healthineers sortiert sein Geschäft neu | Siemens Healthineers setzt einen ungewöhnlich klaren Schnitt im Ultraschallgeschäft. Statt weiterhin möglichst viele medizinische Anwendungen abzudecken, konzentriert sich der Konzern künftig stärker... ► Artikel lesen | |
| GENEDX | 66,32 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| MIMEDX | 4,380 | 0,00 % | Sanara MedTech/MiMedx deal spread widens on FTC second request | ||
| ALIGNMENT HEALTHCARE | 8,415 | +0,18 % | Alignment Healthcare USA, LLC: Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors | ||
| FRESENIUS MEDICAL CARE | 39,600 | +1,43 % | Fresenius Medical Care AG: Kurzfristige Gegenwinde zunehmend eingepreist; Hochstufung auf KAUFEN | Fresenius Medical Care (FME) hat die Prognose für das Geschäftsjahr 2026 bestätigt, wobei auslaufende TDAPA-Effekte, schwache Behandlungsvolumina in den USA und Restrukturierungsaufwendungen das Ergebnis... ► Artikel lesen | |
| PROGYNY | 27,845 | 0,00 % | Progyny, Inc.: Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting | ||
| GERRESHEIMER | 32,160 | -1,71 % | EQS-News: Gerresheimer AG: Gerresheimer steigert EcoVadis-Ratingergebnis und wird erneut mit Gold ausgezeichnet | EQS-News: Gerresheimer AG
/ Schlagwort(e): Nachhaltigkeit/ESG
Gerresheimer steigert EcoVadis-Ratingergebnis und wird erneut mit Gold ausgezeichnet
14.10.2026 / 10:00 CET/CEST
Für... ► Artikel lesen | |
| ADAPTHEALTH | 5,875 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,450 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| CONCENTRA GROUP | 38,200 | +0,08 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 18,280 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |